EMBL in Italy 2022: Emerging approaches in human health and infectious diseases – Alumni relations

Public event

EMBL in Italy 2022: Emerging approaches in human health and infectious diseases


EMBL invites researchers, entrepreneurs, those with an interest in infectious disease, as well as members of its own community – including alumni and staff – to EMBL in Italy 2022: Emerging approaches in human health and infectious diseases on Thursday to Friday 26-27 May 2022. This event is a hybrid event with 85 seats available for in-person attendants on a first-come, first served basis.

The two-day event features senior leaders in industry, biotech startup representatives, experts in data and AI and academic scholars with expertise in infectious diseases. Together, we will cover subjects ranging from pathogens to structural biology and AI, as well as tools for the next pandemic. The event also aims to strengthen ties and highlight resources as well as collaboration opportunities between EMBL, GSK and networks in Italy.

The programme includes a tour of the GSK new science centre, with ample time for a poster session, refreshment breaks and networking. 

This event is open to all and includes coffee breaks and lunch. Space is limited so if you would like to attend in-person, please register as early as possible to secure a spot. You can indicate online or in-person attendance on the registration form.

Who Should Attend:

EMBL in… events are open to all life scientists. The aim is to share what’s happening at EMBL with communities in our EMBL member and associate member states, as well as learn about new and innovative life sciences research and resources available in EMBL host countries. With these events, we seek to open up valuable dialogue, ensuring that as many people as possible have access to the opportunities provided by both EMBL and its alumni and partners.


  • Make valuable connections in Italy
  • Learn about new and exciting research
  • Get to know EMBL and GSK: their community, career opportunities, resources and impact


Day 1Thursday 26 May
12:30-13:00Welcome Coffee, Registration and Networking
13:00-13:30Welcome from GSK and EMBL                               
Chair: Ilaria Ferlenghi, GSK Vaccines
(EMBL Predoc, 1994-1999, Heidelberg)      

Rino Rappuoli, GSK Vaccines & Cornelius Gross, EMBL Rome       
13:30-15:00Innovative approaches in autoimmunity, inflammation, and  host pathogen interactions    
Chairs: Valeria Poli, University of Turin and SIBBM
(EMBL Postdoc, 1988-1990, Heidelberg)      

Maria Bernabeu, EMBL Barcelona
Cosima T. Baldari, Siena University
(EMBL Postdoc, 1978-1980, Heidelberg)
Oretta Finco, GSK Vaccines
Annalisa Chiocchetti, University of Eastern Piedmont
15:00-15:45Coffee and Networking
15:45-17:15Learning from innate & adaptive immune response                           
Chair: Jamie Hackett, EMBL Rome

Maria Zimmerman-Kogadeeva, EMBL Heidelberg
Fabio Bagnoli, GSK Vaccines
Rita Carsetti, Bambin Gesù Hospital Rome
Matteo Iannacone, San Raffaele Institute & University
17:15-19:00Poster Session and Drinks Reception
Chair: Michela Brazzoli, GSK Vaccines
19:00-20:00Aperitivo and buffet
Day 2Friday 27 May
09:00-10:00 Siena Campus and New Science Vaccine Centre Tour
09:15-10:00Coffee and Networking
10:00-10:45Keynote Speaker
Host: Anja Seubert, GSK Vaccines

Sergio Abrignani, Instituto Nazionale di Genetica Molecolare (INGM) and Università Statale of Milan
10:45-11:15Coffee and Networking
11:15-12:45The potential of structural biology & AI in human health and disease
Chair: Alessandro Brozzi, GSK Vaccines

Gaia Pigino, Human Technopole 
Sameer Velankar, EMBL-EBI
Immaculada Margarit y Ros, GSK Vaccines
Joel Karpiak, GSK Pharma
12:45-13:30Buffet Lunch
13:30-14:45Panel discussion: Tools for the next pandemic                       
Chairs: Mariagrazia Pizza, GSK Vaccines & Isabel Delany, GSK Vaccines

Francesco Berlanda-Scorza, R&D Vaccines and GVGH Institute
Claudia Sala, Fondazione Toscana Life Sciences
Sergio Abrignani, Instituto Nazionale di Genetica Molecolare (INGM)
Duccio Medini, Wellcome Leap
Giorgio Guzzetta, Bruno Kessler Foundation
14:45-15:00Closing Remarks:
 Ennio De Gregorio, GSK Vaccines Italy
(EMBL Predoc, 1996-1999, Heidelberg)


Sergio Abrignani

Instituto Nazionale di Genetica Molecolare (INGM)

Fabio Bagnoli

GSK Vaccines

Cosima T. Baldari

Siena University

Francesco Berlanda-Scorza

R&D Vaccines and GVGH Institute

Maria Bernabeu

EMBL Barcelona

Rita Carsetti

Bambin Gesù Hospital Rome

Annalisa Chiocchetti

University of Eastern Piedmont

Oretta Finco

GSK Vaccines

Cornelius Gross


Giorgio Guzzetta

Bruno Kessler Foundation

Matteo Iannacone

San Raffaele Institute & University

Joel Karpiak

GSK Pharma

Immaculada Margarit y Ros

GSK Vaccines

Duccio Medini

Wellcome Leap

Gaia Pigino

Human Technopole

Rino Rappuoli

GSK Vaccines

Claudia Sala

Fondazione Toscana Life Sciences

Sameer Velankar


Maria Zimmerman-Kogadeeva

EMBL Heidelberg


Michela Brazzoli

GSK Vaccines

Alessandro Brozzi

GSK Vaccines

Isabel Delany

GSK Vaccines

Ilaria Ferlenghi

GSK Vaccines

Jamie Hackett


Mariagrazia Pizza

GSK Vaccines

Valeria Poli

University of Turin and SIBBM

Anja Seubert

GSK Vaccines

Poster Session

We are pleased to offer an opportunity for life scientists from all career levels to present a poster at the event. The poster session will take place on Thursday 26 May. Please see below for all relevant information. To submit your abstract or if you have any questions, please contact alumni@embl.org

Poster abstract submission information: Submission deadline: April 25th, 2022

Please apply to one of the three scientific areas: 

1. Innovative approaches in autoimmunity, inflammation, and  host pathogen interactions

2. Learning from innate & adaptive immune response 

3. The potential of structural biology & AI in human health and disease 

  • Abstract should be less than 350 words.
  • No comments, text, or image boxes in the abstract corpus are allowed.
  • All abstracts will be reviewed by the cross EMBL-GSK scientific committee and acceptance is based on scientific content and relevance to meeting topics discussed in the program. 
  • Please note, if the auditorium seats are all taken by the time you register to present a poster, you will be assigned a seat in the joining auditorium where you can watch the talks. This will not affect refreshment breaks which are provided in a large tent for all participants.

Information for Participants

Corona Information
Pursuant to the Law Decree no. 24 of March 24, as of May 1st it will be no longer necessary to give evidence of the Green Pass to access to the workplace. The use of FFP2 face masks remains mandatory indoors. Masks are available at the entrance gate.


GSK Vaccines Campus, Via Florentine 1, Siena. Talks take place in Research Centre (Building 35 on the map below) in the Auditorium on first floor Please see map for all important points. 

Parking: If you are arriving by car, it will be possible to reserve a car-parking but there are limited places. Please e-mail Giulia Corbelli –  giulia.x.corbelli@gsk.com  as soon as possible, asking for a reserved spot. 

Entry to campus: you will have to enter from the Main Entrance gate on VIA FIORENTINA 1, where you will find your GSK-Visitors-Badge. Non-GSK staff have to be escorted by 1 GSK staff member. For this reason, it would be important that you arrive at one of the following time slots: 11:00 11:30 or 12:00 on Day 1 and 8:00 or 8:30 on Day 2. This way, we can provide you with a GSK staff member to walk you to the auditorium. 
If you have questions or need any further information, please do not hesitate alumni@embl.org


Thank you to the following for supporting the event:

Date: 26 - 27 May 2022

Venue: Hybrid: GSK Vaccines, Siena, Italy and online


  • Ennio De Gregorio
    Head of R&D, GSK Vaccines Italy
    • Ilaria Ferlenghi
      Senior Scientific Manager, Head of Structural Microscopy, GSK Vaccines